Single, Double and Triple Blockade of RAAS in Alport Syndrome: Different Tools to Freeze the Evolution of the Disease

Background: The goal of the treatment of Alport syndrome (AS) is to delay the progression of kidney damage. The current standard of care is the use of Renin Angiotensin Aldosterone System (RAAS) blockers: angiotensin-converting enzyme inhibition (ACEi), angiotensin receptor blockade, and, recently,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastrangelo, Antonio, Brambilla, Marta, Romano, Giorgia, Serafinelli, Jessica, Puccio, Giuseppe, Giani, Marisa, Montini, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584724/
https://www.ncbi.nlm.nih.gov/pubmed/34768466
http://dx.doi.org/10.3390/jcm10214946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584724/
https://www.ncbi.nlm.nih.gov/pubmed/34768466
http://dx.doi.org/10.3390/jcm10214946

Ejemplares similares